# Immunogenicity and safety of double dosage of pneumococcal vaccines in adult kidney transplant recipients and waiting list patients: A non-blinded, randomized clinical trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/immunogenicity-and-safety-of-double-dosage-of-pneumococcal-vaccines-in-adult/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lykke Larsen,Claus Bistrup,Søren Schwartz Sørensen,Lene Boesby,Charlotte Sværke Jørgensen,Işık Somuncu Johansen |
| Citations | 13 |
| DOI | 10.1016/j.vaccine.2022.05.040 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.sciencedirect.com/science/article/pii/S0264410X22006351/pdf |
| OpenAlex ID | https://openalex.org/W4281697617 |
| PMID | 35644672 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Lene Boesby](https://scholariq.org/researchers/lene-boesby/)

## Paper journal

- [Vaccine](https://scholariq.org/journals/vaccine/)

## Paper primary topic

- [Pneumonia and Respiratory Infections](https://scholariq.org/topics/pneumonia-and-respiratory-infections/)

## Paper topics

- [Pneumonia and Respiratory Infections](https://scholariq.org/topics/pneumonia-and-respiratory-infections/)
- [Influenza Virus Research Studies](https://scholariq.org/topics/influenza-virus-research-studies/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.